Digital and AI investments in healthcare must be driven by clinical outcomes, not by the availability of technology that can simply be turned on, according to Health New Zealand clinical IT director Dr Andrew Bowers. The comments, shared during HIMSS26 APAC, push back on the common pattern of deploying systems because they exist rather than because they solve a specific patient-care problem.
The clinical outcome test
Bowers framed the challenge in operational terms. Too many organizations, he said, invest in AI based on what the technology can do in a lab or a demo environment. The harder question - and the one that should come first - is whether a given tool will measurably change how a patient is diagnosed, treated, or monitored. Without that link, even sophisticated systems risk becoming expensive shelfware.
The remarks arrive as health systems across Australia, New Zealand, and the broader Asia-Pacific region accelerate their digital transformation programs. Budgets are expanding, but so is scrutiny. Clinical leaders are increasingly asked to justify spending against wait times, diagnostic accuracy, and staff retention metrics rather than IT deployment milestones.
Workflows, not features
Bowers' emphasis on outcomes echoes a wider shift in healthcare AI discussions. At the same HIMSS event, multiple sessions focused on how AI fits into clinical workflows rather than on the feature lists of new products. One presentation detailed how a heart hospital used its EMR maturity as a prerequisite for AI, ensuring that data flowed cleanly before any algorithm was introduced. Another explored how a community hospital designed its physical and digital infrastructure around AI-assisted care pathways from day one.
The common thread is that technology alone does not deliver results. "Digital and AI investments need to be driven by clinical outcomes, not simply by systems that can be switched on," Bowers said. The statement lands differently in 2026 than it would have five years ago, when the industry was still mapping out what AI could theoretically do. Now, with deployments multiplying, the question is what AI actually does.
Leadership and the path forward
HIMSS is doubling down on this conversation. The organization will host a one-day AI Executive Leadership Summit in San Diego on October 21, 2026, followed by its AI in Healthcare Forum from October 22-23. Both events are designed for senior clinical and technology leaders who need to connect investment decisions to measurable health system performance. For professionals building those skills, AI Senior Leadership Courses offer structured learning paths that address the same outcome-focused thinking Bowers described.
Why this matters for healthcare professionals
The signal from HIMSS26 APAC is practical and immediate. If you are evaluating or procuring AI tools, the first question is not "what can this system do?" but "which clinical metric will this improve, and how will we measure it?" Vendors will demo capabilities. Your job is to demand evidence tied to patient outcomes, and to ensure your own data and workflow foundations are solid before any algorithm goes live. For clinicians moving into technology leadership roles, understanding how to make that case - and how to structure AI programs around outcomes rather than features - is quickly becoming a core competency.
Your membership also unlocks:
